Nyckelstudier inom leversjukdomar | GileadPro

FÖRFATTARE TITEL DATUM ÄMNE
j. Grebely et all Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial 01-01-2018 HCV treatment in patients with recent injection drug use
A MANGIA et al. Global real-world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts 01-06-2022 Real world evidence of treatment with SOF/VEL
M P Curry et al Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis 01-11-2015 SOF VEL treatment in patients with Decompensated Cirrhosis
G R Foster et all Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis 01-06-2016 DAA treatment in patients with Decompensated Cirrhosis
S Blach et al Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID-19 01-06-2021 HCV Elimination in Sweden
JJ Feld et al Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection 01-12-2015 SOF VEL treatment in GT 1,2,4,5-6
Kontakta oss

Kontakta våra sälj- och medicinska team

Har du frågor om våra läkemedel eller produkter? Kontakta oss.

Kontakta oss Kontakta våra medicinska team

SE-COR-0040; March 2023